Orexo, Invida sign supply pact
As per the terms of the agreement, Orexo is expected to take up the responsibly for supplying Abstral product to Invida. However, Invida will be responsible for all
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Raman Extended Computational Application Platform (RECAP) brings patented technology in computational sensors, materials verification and identification software to developers, solutions providers and equipment suppliers. Centice claims Recap is